8 March 2023 - Spikevax bivalent Original/Omicron BA.4-5 mRNA vaccine authorised for people aged 18 and over.
Swissmedic has issued an unlimited authorisation for the bivalent vaccine Spikevax bivalent Original/Omicron BA.4-5. It covers the Omicron sub-variants BA.4 and BA.5 in addition to the original SARS-CoV-2 strain.